Urology Protocols

MULTI-001 Nivolumab v11

MULTI-002 Carboplatin and etoposide v1

MULTI-004 Atezolizumab (SC/IV) v13

MULTI-018 Larotrectinib v2

MULTI-019 Entrectinib v2

MULTI-024 Avelumab v2

MULTI-029 Olaparib v2

URO-003 Docetaxel + prednisolone for hormone refractory Metastatic Prostate Cancer v5

URO-021 Abiraterone and prednisolone v5

URO-022 Enzalutamide v6

URO-026 Docetaxel + prednisolone for hormone naïve Metastatic Prostate Cancer v4

URO-027 CarboMV v1

URO-029 Carboplatin & Paclitaxel v2

URO-030 Paclitaxel & Gemcitabine v2

URO-032 CX for penile cancer v1

URO-035 Darolutamide in combination with ADT v2

URO-036 Apalutamide in combination with ADT v4

URO-037 Gemcitabine with radiotherapy v1

URO-038 Darolutamide with docetaxel and ADT v2

URO-039 Olaparib in combination with abiraterone v1